(Q37988573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Using NF-κB as a molecular target for theranostics in radiation oncology research (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Yu-Chang Liu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

I-Tsang Chiang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jeng-Jong Hwang

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

139-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

Missing pieces in the NF-kappaB puzzle

24 January 2020

cites work

1 reference

Nuclear factor-kappaB: the enemy within

21 January 2018

1 reference

The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy

21 January 2018

1 reference

Immunity, Inflammation, and Cancer

21 January 2018

1 reference

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression

21 January 2018

1 reference

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

Contradictory functions of NF-kappaB in liver physiology and cancer

21 January 2018

1 reference

NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer

21 January 2018

1 reference

The ATM protein is required for sustained activation of NF-kappaB following DNA damage

21 January 2018

1 reference

NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment.

21 January 2018

1 reference

Regulation of activity and function of the p52 NF-κB subunit following DNA damage

21 January 2018

1 reference

Active roles for inhibitory kappaB kinases alpha and beta in nuclear factor-kappaB-mediated chemoresistance to doxorubicin

21 January 2018

1 reference

Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells

21 January 2018

1 reference

RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin.

21 January 2018

1 reference

Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model

21 January 2018

1 reference

Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity

21 January 2018

1 reference

Induction of autophagic cell death and radiosensitization by the pharmacological inhibition of nuclear factor-kappa B activation in human glioma cell lines

21 January 2018

1 reference

Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ.

21 January 2018

1 reference

Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors

21 January 2018

1 reference

Addressing reported pro-apoptotic functions of NF-kappaB: targeted inhibition of canonical NF-kappaB enhances the apoptotic effects of doxorubicin

21 January 2018

1 reference

Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation

21 January 2018

1 reference

Activated nuclear factor-kappa B and cytokine profiles in the esophagus parallel tumor regression following neoadjuvant chemoradiotherapy

21 January 2018

1 reference

Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer

21 January 2018

1 reference

Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence

21 January 2018

1 reference

Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

21 January 2018

1 reference

Nuclear factor κ-light chain-enhancer of activated B cells is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiotheraphy

21 January 2018

1 reference

Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.

21 January 2018

1 reference

Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis.

21 January 2018

1 reference

Overexpression of Forkhead Box M1 transcription factor and nuclear factor-κB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis

21 January 2018

1 reference

Association of constitutive nuclear factor-kappaB activation with aggressive aspects and poor prognosis in cervical cancer.

21 January 2018

1 reference

NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer

21 January 2018

1 reference

Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma

21 January 2018

1 reference

NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy

21 January 2018

1 reference

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways.

21 January 2018

1 reference

Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.

21 January 2018

1 reference

First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting

21 January 2018

1 reference

Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1.

21 January 2018

1 reference

Curcumin and gemcitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

Potential pharmacological control of the NF-κB pathway

21 January 2018

1 reference

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

21 January 2018

1 reference

Phase II study of concomitant thalidomide during radiotherapy for hepatocellular carcinoma

21 January 2018

1 reference

Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy

21 January 2018

1 reference

Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies

21 January 2018

1 reference

Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives

21 January 2018

1 reference

Radiation therapy and sorafenib: clinical data and rationale for the combination in metastatic renal cell carcinoma

21 January 2018

1 reference

Combination of sorafenib and intensity modulated radiotherapy for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice.

21 January 2018

1 reference

NF-kappaB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy.

21 January 2018

1 reference

Sorafenib and radiation: a promising combination in colorectal cancer.

21 January 2018

1 reference

Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo

21 January 2018

1 reference

Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme

21 January 2018

1 reference

[Sorafenib and radiotherapy association for hepatocellular carcinoma].

21 January 2018

1 reference

Immunohistochemical study of nuclear factor-kappaB activity and interleukin-8 abundance in oesophageal adenocarcinoma; a useful strategy for monitoring these biomarkers.

21 January 2018

1 reference

Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens

21 January 2018

1 reference

The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus.

21 January 2018

1 reference

Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.

21 January 2018

1 reference

Hairpin-like fluorescent probe for imaging of NF-κB transcription factor activity

21 January 2018

1 reference

Noninvasive nuclear factor-kappaB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice.

21 January 2018

1 reference

Molecular imaging of nuclear factor-κB in bladder as a primary regulator of inflammatory response

21 January 2018

1 reference

Cytokine-based transformation of immune surveillance into tumor-promoting inflammation

21 January 2018

1 reference

Cancer immunoediting from immune surveillance to immune escape

21 January 2018

1 reference

Bowel perforation after radiotherapy in a patient receiving sorafenib.

21 January 2018

1 reference

Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib

21 January 2018

1 reference

Severe acute enteritis in a multiple myeloma patient receiving bortezomib and spinal radiotherapy: case report

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.12.2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22369374%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference